Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023

Background The global proliferation of unregistered and falsified medicinal products poses significant public health risks. In Malaysia, previous studies have shown concerning prevalence rates but are often limited to specific populations and targeted product brands, restricting the generalisability...

Full description

Bibliographic Details

Main Authors:	Khairul Anuar Abdul Karim, Asyraf Elmiza Ahmad, Mohd Zawawi Abdullah, Asniza Alias, Salina Setan, Manzatul Azrul Azrie Sulaiman, Nor Ilham ‘Ainaa Muhsin
Format:	Artigo
Language:	Inglês
Published:	Taylor & Francis Group 2025-12-01
Series:	Journal of Pharmaceutical Policy and Practice
Subjects:	Prevalence unregistered falsified medicinal products Malaysia
Online Access:	https://www.tandfonline.com/doi/10.1080/20523211.2025.2557879
Tags:	Add Tag No Tags, Be the first to tag this record!